Moderate

Enteropathic arthritis

Arthritis with inflammatory bowel disease · Rheumatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

A seronegative spondyloarthropathy associated with inflammatory bowel disease, presenting as peripheral arthritis, axial disease or enthesitis. Peripheral type 1 oligoarthritis often parallels gut activity, whereas axial disease runs an independent course.

Red flags

  • Hot swollen joint raising concern for septic arthritis
  • Inflammatory back pain with progressive stiffness
  • GI bleeding or obstruction (active IBD)
  • New uveitis (red painful eye)
  • Systemic sepsis

Assessment

Differential diagnosis

  • Ankylosing spondylitis / axial SpA
  • Psoriatic arthritis
  • Reactive arthritis
  • Septic arthritis
  • Crystal arthropathy
  • IBD-related drug reaction (arthralgia)

Investigations

  • CRP/ESR and faecal calprotectin (gut activity)
  • HLA-B27 (associated with axial disease)
  • Joint aspiration if monoarthritis to exclude sepsis/crystals
  • Radiographs / MRI sacroiliac joints for axial disease
  • Colonoscopy/assessment of IBD activity
  • RF and anti-CCP (negative) to exclude RA

Management

  • Classify the pattern: peripheral type 1 (pauci-articular, gut-linked), type 2 (polyarticular, independent) or axial
  • Exclude septic arthritis in any acute monoarthritis
  • Treat the underlying bowel disease, which often controls type 1 peripheral arthritis
  • Use simple analgesia and intra-articular steroids; avoid/limit NSAIDs that can flare IBD
  • For persistent peripheral disease use sulfasalazine or methotrexate
  • For axial disease and refractory peripheral disease use anti-TNF therapy that treats both gut and joints
  • Provide physiotherapy for axial disease
  • Coordinate care jointly between gastroenterology and rheumatology

Drugs & doses

Sulfasalazine — 500 mg PO BD increasing to 1 g BD for peripheral arthritis
Methotrexate — 15-25 mg PO/SC once weekly with folic acid
Infliximab — 5 mg/kg IV at 0, 2, 6 weeks then 8-weekly (treats gut and joints)
Adalimumab — 40 mg SC every 2 weeks
Prednisolone — intra-articular or short oral course for flares (avoid prolonged NSAIDs)

Disposition

Outpatient joint gastroenterology-rheumatology care; admit for septic arthritis exclusion or severe IBD flare.

Complications & pitfalls

  • Progressive axial ankylosis
  • Acute anterior uveitis
  • Joint damage if untreated
  • IBD flare precipitated by NSAIDs
  • Enthesitis-related disability

Exam pearls

  • Avoid long-term NSAIDs where possible as they can exacerbate IBD
  • Anti-TNF agents (infliximab, adalimumab) treat both the gut and the joints; etanercept treats joints but not the bowel
  • Type 1 peripheral arthritis tracks bowel activity; axial disease does not
  • Always screen acute monoarthritis for infection before intra-articular steroid

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.